Back to Search
HAYDEN SANDLER, MD
MD
Body Imaging Physician
NPI: 1659803013IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Body Imaging PhysicianPrimary
Radiology — Body Imaging
Code: 2085B0100X
313776(NY)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
313776(NY)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
OTHER
Class of 2017
Research & Publications (20)
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
PMID 19394158·Int J Radiat Oncol Biol Phys·2010
6-review
Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost.
PMID 19409729·Int J Radiat Oncol Biol Phys·2010
4-observational
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.
PMID 19577865·Int J Radiat Oncol Biol Phys·2010
3-trial
Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.
PMID 19211454·J Natl Cancer Inst·2009
3-trial
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
PMID 18990504·Int J Radiat Oncol Biol Phys·2009
3-trial
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
PMID 19100600·Urology·2009
3-trial
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
PMID 19047297·J Clin Oncol·2009
3-trial
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Determining if pretreatment PSA doubling time predicts PSA trajectories after radiation therapy for localized prostate cancer.
PMID 18977051·Radiother Oncol·2009
8-other
Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.
PMID 19307511·J Clin Oncol·2009
2-rct
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.
PMID 19636019·J Clin Oncol·2009
3-trial
Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial.
PMID 18977098·Int J Radiat Oncol Biol Phys·2009
3-trial
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
PMID 18947941·Int J Radiat Oncol Biol Phys·2009
4-observational
Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancer.
PMID 19147014·Int J Radiat Oncol Biol Phys·2009
8-other
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 19103723·J Clin Oncol·2009
8-other
No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer.
PMID 18722651·Urology·2009
8-other
Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts.
PMID 19014779·Int J Radiat Oncol Biol Phys·2008
4-observational
CounterPoint: second malignancies after radiotherapy for prostate cancer: keeping perspective.
PMID 18817957·Urology·2008
8-other
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
PMID 18779620·J Clin Oncol·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 215 SE 8TH AVE APT 3070
FT LAUDERDALE, FL 33301 - Phone
- (954) 593-0058
Quick Facts
- NPI
- 1659803013
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile